drugset / Trial / NCT01255501
First in Human Study of NI-0701 in Healthy Volunteers
Summary
The purpose of this study is to determine the safety, pharmacodynamic and pharmacokinetic profiles of a novel therapeutic drug when administered to healthy volunteers.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NI-0701 | Unknown | — | Intravenous |
Indications
No indication recorded.